Cytek Biosciences

Manufacturer of flow cytometry systems for research applications

placeSan Francisco, California, United States calendar_todayFounded 2014 groups676 employees language cytekbio.com

Registered entities

Innovation

37 patent families (14 granted) — focus: Physics & computing, Operations & transport, Electricity & electronics, Chemistry & metallurgy; filing pace accelerating. Cited 789 times.

YearFilings
20161
20173
20187
20195
20207
20215
20229
20239
202420
202517
20266

Social engagement

Social engagement: 37.2K social following, 11 posts in the last 12 months — below the industry typical range.

Investor mix

14 investors on record; lead investors include NLVC, 3E BioVentures, RA Capital Management, Hillhouse; 1 has since exited.

Investor typeCountShare
Venture capital1179%
Private equity214%
Other / undisclosed17%

Hiring activity

Hires periodically

5 roles tracked across 4 of the last 12 months

5 Mar 2026 · Buyer/ Planner · Fremont

2 Mar 2026 · Contract Specialist · Fremont

6 Feb 2026 · Director/Sr. Director, Reagent Operations · San Diego

6 Jan 2026 · Instrument Coordinator and Service Sales · Bethesda

11 Nov 2025 · Sr. Financial Planner and Analyst · Fremont

Based on job postings tracked across public sources.

Recent activity

30 Jun 2026
Product launch
Cytek® cFluor® Resource Center
29 Jun 2026
Event
A Practical Spectral Flow Cytometry Approach To Classify Functional Subsets Of Human T Cells
22 Jun 2026
Event
Shining Light On The Antigen-Specific CD8+ T Cell Landscape Using Spectral Flow Cytometry And Combinatorial Tetramer Staining
Coming soon